Newly developed treatment offers more effective approach to fight pediatric brain cancer
November 7, 2018
Researchers have identified the group of children who require a more rigorous chemotherapy treatment for a common form of brain cancer. They have found a chromosome pattern in medulloblastoma which would allow medics to adjust treatments for each child individually, increasing the survival rate to 60% for higher risk patients.
Medulloblastoma is the most common form of childhood brain cancer according to researchers. Additionally, these findings have determined that many young children with this form of cancer could potentially avoid unneeded doses of chemotherapy and consequently reduce toxicity and side effects.